Stock Events

Stock Events

Oxford Nanopore Technologies 

$1.6
55
+$0.11+7.24% Thursday 13:30

Statistics

Day High
1.45
Day Low
1.41
52W High
3.34
52W Low
1.24
Volume
3,600
Avg. Volume
17,024
Mkt Cap
1.54B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2MarExpected
Q2 2022
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-9.99
-6.68
-3.36
-0.04
Expected EPS
-7.016609210832
Actual EPS
-7.03177776

Financials

-65.46%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
747.22MRevenue
-489.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONTTF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, competing directly in the DNA sequencing market.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences provides long-read sequencing technologies, directly competing with Oxford Nanopore's long-read sequencing capabilities.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a range of sequencing solutions and genetic analysis tools, competing in the broader genomics and molecular diagnostics market.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products, including droplet digital PCR systems, which compete in the genomics space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid technology market.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG, through its acquisition of GenMark Diagnostics, competes in the next-generation sequencing and molecular diagnostics market.
Agilon Health
AGL
Mkt Cap330.09M
Agilent Technologies provides instruments, services, consumables, applications, and expertise, competing in the life sciences and applied chemical markets for genomics and molecular diagnostics.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics offers the Saphyr system for genome analysis, competing in the structural variation detection and genome mapping space.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics markets with a focus on next-generation sequencing.

About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Show more...
CEO
Dr. Gurdial Singh Sanghera Ph.D.
Employees
1382
Country
GB
ISIN
GB00BP6S8Z30

Listings

F
DE
4R0.F
OTC Link
US
ONTTF
LSE
GB
ONT.LSE
OTC Link
US
OXFYY

0 Comments

Share your thoughts

FAQ

What is Oxford Nanopore Technologies stock price today?▼
The current price of ONTTF is $1.6 USD — it has increased by +7.24% in the past 24 hours. Watch Oxford Nanopore Technologies stock price performance more closely on the chart.
What is Oxford Nanopore Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Oxford Nanopore Technologies stocks are traded under the ticker ONTTF.
Is Oxford Nanopore Technologies stock price growing?▼
ONTTF stock has risen by +4.58% compared to the previous week, the month change is a -2.44% fall, over the last year Oxford Nanopore Technologies has showed a +20.3% increase.
What is Oxford Nanopore Technologies market cap?▼
Today Oxford Nanopore Technologies has the market capitalization of 1.54B
When is the next Oxford Nanopore Technologies earnings date?▼
Oxford Nanopore Technologies is going to release the next earnings report on August 19, 2026.
What were Oxford Nanopore Technologies earnings last quarter?▼
ONTTF earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.09 USD resulting in a -0.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Oxford Nanopore Technologies revenue for the last year?▼
Oxford Nanopore Technologies revenue for the last year amounts to 747.22M USD.
What is Oxford Nanopore Technologies net income for the last year?▼
ONTTF net income for the last year is -489.13M USD.
How many employees does Oxford Nanopore Technologies have?▼
As of April 05, 2026, the company has 1,382 employees.
In which sector is Oxford Nanopore Technologies located?▼
Oxford Nanopore Technologies operates in the Health Care sector.
When did Oxford Nanopore Technologies complete a stock split?▼
Oxford Nanopore Technologies has not had any recent stock splits.
Where is Oxford Nanopore Technologies headquartered?▼
Oxford Nanopore Technologies is headquartered in Oxford, GB.